Preclinical mammalian safety studies of EPHARNA (DOPC...

  • Main
  • 2017 / 03
  • Preclinical mammalian safety studies of EPHARNA (DOPC...
Molecular Cancer Therapeutics 2017 / 03

Preclinical mammalian safety studies of EPHARNA (DOPC nanoliposomal EphA2-targeted siRNA)

Wagner, Michael J., Mitra, Rahul, McArthur, Mark J., Baze, Wallace, Barnhart, Kirstin, Wu, Sherry, Rodriguez-Aguayo, Cristian, Zhang, Xinna, Coleman, Robert L., Lopez-Berestein, Gabriel, Sood, Anil K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-16-0541
Date:
March, 2017
File:
PDF, 891 KB
english, 2017
Conversion to is in progress
Conversion to is failed